| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |